Targeting cell-state plasticity driven by FOXM1/CEBPB axis disrupts developmental heterogeneity and therapeutic resistance in hepatocellular carcinoma

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (82372714)
  • National Natural Science Foundation of China (82303022)
  • National Natural Science Foundation of China (82203380)
  • National Natural Science Foundation of China (82122048)
  • National Key Research and Development Program of China (2024YFE0215600)
  • Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515011416)
  • Basic and Applied Basic Research Foundation of Guangdong Province (2024A04J6575)